SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE

被引：0
|
作者：
Fleischmann, Roy [1 ,2 ]
Meerwein, Sebastian [3 ]
Charles-Schoeman, Christina [4 ]
Combe, Bernard [5 ]
Hall, Stephen [6 ,7 ]
Khan, Nasser [8 ]
Carter, Kyle [9 ]
Camp, Heidi [10 ]
Rubbert-Roth, Andrea [11 ]
机构：
[1] Metroplex Clin Res Ctr, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX USA
[3] AbbVie Deutsch GmbH Co KG, Ludwigshafen, Germany
[4] Univ Calif Santa Monica, Div Rheumatol, Santa Monica, CA USA
[5] Montpellier Univ, Montpellier, France
[6] Emeritus Res, Melbourne, Vic, Australia
[7] Monash Univ, Melbourne, Vic, Australia
[8] AbbVie Inc, Abbott Pk, IL USA
[9] AbbVie Inc, N Chicago, IL USA
[10] AbbVie, Winnetka, IL USA
[11] Cantonal Clin St Gallen, Div Rheumatol, St Gallen, Switzerland
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARA-P87
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST GENERATION JAK INHIBITORS
    Kamiya, M.
    Mori, S.
    Yamazaki, K.
    Togawa, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [2] Long-Term Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to CsDMARDs: Results at 60 Weeks
    Burmester, Gerd
    Van den Bosch, Filip
    Bessette, Louis
    Kivitz, Alan
    Li, Yihan
    Friedman, Alan
    Pangan, Aileen
    Camp, Heidi
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] EFFICACY AND SAFETY OF UPADACITINIB IN TNFI INADEQUATE RESPONDERS WITH RHEUMATOID ARTHRITIS FROM THREE PHASE 3 CLINICAL TRIALS
    Fleischmann, Roy
    Bessette, Louis
    Hall, Stephen
    Sparks, Jeffrey
    Jain, Manish
    Kakehasi, Adriana
    Song, Yanna
    Meerwein, Sebastian
    DeMasi, Ryan
    Suboticki, Jessica
    Rubbert-Roth, Andrea
    RHEUMATOLOGY, 2023, 62
  • [4] The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    Kameda, Hideto
    Khan, Nasser
    Sasaki, Nobuhito
    Harigai, Masayoshi
    Song, Yanna
    Zhang, Ying
    Takeuchi, Tsutomu
    DRUG SAFETY, 2021, 44 (06) : 711 - 722
  • [5] The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
    Kunihiro Yamaoka
    Yoshiya Tanaka
    Hideto Kameda
    Nasser Khan
    Nobuhito Sasaki
    Masayoshi Harigai
    Yanna Song
    Ying Zhang
    Tsutomu Takeuchi
    Drug Safety, 2021, 44 : 711 - 722
  • [6] The Safety Profile of Upadacitinib in Japanese Patients with Rheumatoid Arthritis
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    Kameda, Hideto
    Hendrickson, Barbara
    Meerwein, Sebastian
    Zhang, Ying
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [7] The efficacy and safety of abatacept or infliximab in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Becker, J. C.
    Li, T.
    Schiff, M.
    RHEUMATOLOGY, 2008, 47 : II14 - II15
  • [8] Upadacitinib: safety profile in rheumatoid arthritis
    Reactions Weekly, 2020, 1830 (1) : 11 - 11
  • [9] UPADACITINIB. EFFECTIVENESS AND SAFETY IN PATIENTS WITH REFRACTORY RHEUMATOID ARTHRITIS
    Ruiz, N. Roldan
    Giraldez, C. Ramos
    Perez, C. Azabal
    Martinez, R.
    Feijoo, M. L. Velloso
    Marenco, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1336 - 1336
  • [10] Efficacy and Safety of Tofacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Prior Therapies
    Tesser, John
    Gul, Ahmet
    Olech, Ewa
    Oelke, Kurt
    Lukic, Tatjana
    Murray, Christopher W.
    Zang, Chuanbo
    Takiya, Liza
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345